NastLaw is committed to providing the latest information on the Nexium, Prilosec, Prevacid Lawsuit Status. Many lawsuits have been filed and are being investigated for claims that Nexium, Prilosec or Prevacid products, known as Proton Pump Inhibitors, commonly referred to as PPI’s, cause chronic kidney disease or other serious kidney injuries. We will provide ongoing updates on the Proton Pump … Read More
Talcum Powder Lawsuit Status
NastLaw is committed to providing the latest information on the Talcum Powder Lawsuit Status. Several hundred lawsuits have been filed and thousands more are being investigated for claims that talcum powder in several popular Johnson and Johnson (J&J) products causes ovarian cancer. We will provide ongoing updates on the Talcum Powder Lawsuit status, check back for the latest information. If … Read More
Invokana Lawsuit Status
Lawsuits are being filed against Janssen Pharmaceuticals and their parent company Johnson & Johnson, the manufacturers of the diabetes drug Invokana, for failing to warn about several serious and potentially deadly side effects, like ketoacidosis. If you are looking for information on how to file an Invokana lawsuit, please call us toll free at 1-888-532-4719, or use our online form … Read More
Testosterone Lawsuit Status
NastLaw is committed to providing the latest information on the Testosterone Lawsuit Status. The testosterone case has many products and many defendants in it, which makes the case very complex. If you are looking for information on how to file a Testosterone lawsuit, please call us toll free at 1-888-532-4719, or use our online form for a free, no obligation … Read More
Johnson & Johnson Mired in Legal Troubles
Johnson & Johnson, one of the largest healthcare product manufacturers in the world, has been forced to defend itself against numerous product defect claims in recent years. Some have stemmed from products being defectively designed, and others have arisen from Johnson & Johnson’s failure to adequately warn customers of the potential risks of its products. Talcum Powder Products For decades, … Read More
FDA Recalls
If the FDA identifies a violation of the law it is entrusted to enforce, the agency may take action in the interest of public safety. One way the agency protects consumers from unsafe drugs and medical devices post-approval is through an FDA recall. Drug companies and device manufacturers often go along with FDA recalls voluntarily. In some cases, however, they … Read More
The FDA Approval Process
The road toward Food and Drug Administration (FDA) approval begins long before the agency actually gets involved. The pharmaceutical company starts with its own laboratory research and animal trials. Later, it takes the first formal step in the FDA’s pharmaceutical approval process by submitting an investigational new drug (IND) application. The medical device approval process follows a similar path. The … Read More
About the FDA
What is the FDA? The Food and Drug Administration (FDA) is a federal agency within the U.S. Department of Health and Human Services. The FDA has broad regulatory authority over not just food and drugs, but also biologics such as vaccines, medical devices, tobacco products, certain cosmetics, and some veterinary products. The agency was formed in 1906 and today employs … Read More
Daniel Gallucci Presenting at Harris Martin MDL Conference
NastLaw attorney Daniel Gallucci will be speaking at the upcoming HarrisMartin MDL Conference on September 28th, 2016. Topics covered in the conference include: Talcum Powder Proton Pump Inhibitors ELIQUIS Essure Taxotere Roundup Mr. Gallucci will providing an update on the Proton Pump Inhibitor litigation along with Neil D. Overholtz of Aylstock, Witkin, Kreis and Overholtz. The conference will be chaired … Read More
Proton Pump Inhibitor Litigation Conference Recap
NastLaw was pleased to be a part of the HarrisMartin Proton Pump Inhibitors – Kidney Injury Litigation conference on June 15th, 2016. Daniel Gallucci of NastLaw co-chaired the event along with Neil Overholtz of Aylstock, Witkin, Kreis & Overholtz, and Paul Pennock of Weitz & Luxenberg. The conference was very well attended, showing a strong interest in the litigation from … Read More
- Page 1 of 2
- 1
- 2